Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-11-16 Sale |
2022-11-18 8:13 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
3,612 | $4.49 | $16,218 | 127,586 (Direct) |
View |
2022-11-16 Sale |
2022-11-18 8:13 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
6,255 | $4.4902 | $28,086 | 191,334 (Direct) |
View |
2022-08-16 Sale |
2022-08-18 6:24 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
14,806 | $5.035 | $74,548 | 457,287 (Direct) |
View |
2022-08-16 Sale |
2022-08-18 6:21 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
4,124 | $5.034 | $20,760 | 158,882 (Direct) |
View |
2022-08-16 Sale |
2022-08-18 6:21 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
3,430 | $5.0347 | $17,269 | 131,198 (Direct) |
View |
2022-08-16 Sale |
2022-08-18 6:20 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
5,940 | $5.035 | $29,908 | 197,589 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 4:48 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
14,220 | $7.2 | $102,384 | 472,093 (Direct) |
View |
2022-06-08 Sale |
2022-06-10 4:20 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
5,853 | $5.63 | $32,952 | 203,529 (Direct) |
View |
2022-05-17 Sale |
2022-05-19 5:20 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
3,223 | $5.3163 | $17,134 | 133,735 (Direct) |
View |
2022-05-17 Sale |
2022-05-19 5:16 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
5,582 | $5.3162 | $29,675 | 207,592 (Direct) |
View |
2022-05-17 Sale |
2022-05-19 5:08 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
3,873 | $5.318 | $20,597 | 163,006 (Direct) |
View |
2022-05-17 Sale |
2022-05-19 5:04 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
13,913 | $5.316 | $73,962 | 486,313 (Direct) |
View |
2022-03-01 Sale |
2022-03-03 7:02 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
3,763 | $9.8564 | $37,090 | 328,281 (Direct) |
View |
2022-03-01 Sale |
2022-03-03 7:02 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
2,221 | $9.856 | $21,890 | 314,452 (Direct) |
View |
2022-03-01 Sale |
2022-03-03 7:02 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
8,828 | $9.856 | $87,009 | 839,645 (Direct) |
View |
2022-03-01 Sale |
2022-03-03 7:02 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
2,577 | $9.8566 | $25,400 | 234,356 (Direct) |
View |
2022-02-10 Sale |
2022-02-14 5:42 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $16 | $80,000 | 348,094 (Direct) |
View |
2022-02-07 Sale |
2022-02-09 4:35 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
2,496 | $14.46 | $36,096 | 155,702 (Direct) |
View |
2022-01-03 Sale |
2022-01-05 4:47 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $16.01 | $80,050 | 353,094 (Direct) |
View |
2021-12-01 Sale |
2021-12-03 4:15 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $17.94 | $89,689 | 358,094 (Direct) |
View |
2021-11-16 Sale |
2021-11-18 5:55 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
8,402 | $17.12 | $143,816 | 328,489 (Direct) |
View |
2021-11-16 Sale |
2021-11-18 5:54 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe Chief Operations Officer |
3,332 | $17.12 | $57,034 | 113,097 (Direct) |
View |
2021-11-16 Sale |
2021-11-18 5:53 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
2,124 | $17.12 | $36,356 | 87,540 (Direct) |
View |
2021-11-16 Sale |
2021-11-18 5:53 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
3,655 | $17.12 | $62,562 | 157,714 (Direct) |
View |
2021-11-16 Sale |
2021-11-18 5:52 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
2,199 | $17.12 | $37,640 | 90,594 (Direct) |
View |
2021-11-15 Sale |
2021-11-17 4:15 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe Chief Operations Officer |
7,000 | $17.71 | $124,004 | 158,429 (Direct) |
View |
2021-11-04 Sale |
2021-11-05 4:28 pm |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
13,354 | $19.5 | $260,403 | 31,500 (Direct) |
View |
2021-11-02 Sale |
2021-11-04 4:10 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $16.41 | $82,050 | 365,293 (Direct) |
View |
2021-09-22 Sale |
2021-09-24 5:35 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe Chief Operations Officer |
10,500 | $17 | $178,500 | 165,429 (Direct) |
View |
2021-09-15 Sale |
2021-09-17 4:36 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe Chief Operations Officer |
3,116 | $15.61 | $48,647 | 119,929 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Gallagher Carol Giltner Director |
52,000 | $0 | 163,918 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | HEIDEN WILLIAM K Director |
52,000 | $0 | 83,500 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
52,000 | $0 | 83,500 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | MALLIK AMEET Director |
52,000 | $0 | 52,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Roncarolo Maria Grazia Director |
52,000 | $0 | 63,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Baynes Roy D. Director |
52,000 | $0 | 75,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | DOBMEIER ERIC Director |
52,000 | $0 | 91,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Renaud Ronald C JR Director |
52,000 | $0 | 63,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | SEIDENBERG BETH C Director |
52,000 | $0 | 1,967,233 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
176,342 | $0 | 328,281 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
226,079 | $0 | 314,452 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Yarema Kristin Chief Commercial Officer |
131,125 | $0 | 257,007 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
519,984 | $0 | 839,645 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
149,212 | $0 | 234,356 (Direct) |
View |
2022-02-10 Exercise |
2022-02-14 5:42 pm |
N/A 2030-05-13 |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $0 | 348,094 (Direct) |
View |
2022-02-10 Exercise |
2022-02-14 5:42 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $9.58 | 348,094 (Direct) |
View |
2022-01-03 Exercise |
2022-01-05 4:47 pm |
N/A 2030-05-13 |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $0 | 353,094 (Direct) |
View |
2022-01-03 Exercise |
2022-01-05 4:47 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $9.58 | 353,094 (Direct) |
View |
2021-12-01 Exercise |
2021-12-03 4:15 pm |
N/A 2030-05-13 |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $0 | 358,094 (Direct) |
View |
2021-12-01 Exercise |
2021-12-03 4:15 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $9.58 | 358,094 (Direct) |
View |
2021-11-15 Exercise |
2021-11-17 4:15 pm |
N/A 2030-02-28 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe Chief Operations Officer |
3,500 | $0 | 158,429 (Direct) |
View |
2021-11-15 Exercise |
2021-11-17 4:15 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe Chief Operations Officer |
3,500 | $12.15 | 158,429 (Direct) |
View |
2021-11-02 Exercise |
2021-11-04 4:10 pm |
N/A 2030-05-13 |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $0 | 365,293 (Direct) |
View |
2021-11-02 Exercise |
2021-11-04 4:10 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $9.58 | 365,293 (Direct) |
View |
2021-09-22 Exercise |
2021-09-24 5:35 pm |
N/A 2030-02-28 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe Chief Operations Officer |
10,500 | $17 | 165,429 (Direct) |
View |
2021-09-22 Exercise |
2021-09-24 5:35 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe Chief Operations Officer |
10,500 | $12.15 | 165,429 (Direct) |
View |